O'Shaughnessy Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-153	Closed	-$10K	–	2039
2020 Q2	$10K	Sell	153 -70	-31%	-$4.69K	﹤0.01%	1266
2020 Q1	$14K	Sell	223 -249	-53%	-$18.4K	﹤0.01%	985
2019 Q4	$42K	Buy	472 +315	+201%	+$26.6K	﹤0.01%	1003
2019 Q3	$12K	Sell	157 -386	-71%	-$31.3K	﹤0.01%	785
2019 Q2	$46K	Buy	+543	New	+$53.7K	﹤0.01%	735

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

O'Shaughnessy Asset Management's TARO Position: Q3 2020 in Review

O'Shaughnessy Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2020, closing a stake of 153 shares — an estimated $10K sold.

O'Shaughnessy Asset Management first reported a position in TARO in Q2 2019 and held it in 5 quarters. The position peaked at $46K in Q2 2019. 78 funds tracked by Wall St. Rank hold TARO as of Q3 2020.

O'Shaughnessy Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2020 after selling out during the quarter.
O'Shaughnessy Asset Management sold 153 Taro Pharmaceutical Industries Ltd. shares in Q3 2020, an estimated $10K.
O'Shaughnessy Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2019 and held it in 5 quarters.
O'Shaughnessy Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $46K in Q2 2019.
78 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2020.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.